Notice2023-05822
Notice of Award of a Single-Source Cooperative Agreement To Fund the Ethiopian Public Health Institute
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 22, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), announces the award of approximately $12,000,000, for Year 1 funding to the Ethiopian Public Health Institute (EPHI). The award will address gaps identified in national HIV laboratory and surveillance systems and pave the way for HIV epidemic control in Ethiopia.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 55 (Wednesday, March 22, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 55 (Wednesday, March 22, 2023)]
[Notices]
[Pages 17227-17228]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-05822]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
the Ethiopian Public Health Institute
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), within
the Department of Health and Human Services (HHS), announces the award
of approximately $12,000,000, for Year 1 funding to the Ethiopian
Public Health Institute (EPHI). The award will address gaps identified
in national HIV laboratory and surveillance systems and pave the way
for HIV epidemic control in Ethiopia.
DATES: The period for this award will be September 30, 2023, through
September 29, 2028. Funding amounts for years 2-5 will be set at
continuation.
FOR FURTHER INFORMATION CONTACT: Yared Tedla, Center for Global Health,
Centers for Disease Control and Prevention, U.S. Embassy, P.O. Box
[[Page 17228]]
1014, Addis Ababa, Ethiopia, Telephone: 404.718.4293, E-Mail:
<a href="/cdn-cgi/l/email-protection#3f474555067f5c5b5c11585049"><span class="__cf_email__" data-cfemail="463e3c2c7f0625222568212930">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The single-source award will support an
integrated laboratory system for multiplexing testing of HIV, TB, and
other pathogens in an optimized diagnostic network using point-of-care
or conventional platforms. Routine viral load monitoring will be scaled
up to reach all eligible clients on treatment, with consideration of
alternate specimen collection modalities, and cold chain
infrastructure.
The Ethiopian Public Health Institute (EPHI) is in a unique
position to conduct this work, as it is the sole federal government
agency accountable to the Ministry of Health (MOH) that is mandated to
oversee and coordinate the following main areas of work: undertake
research; generate, absorb and disseminate scientific knowledge to
improve public health; conduct surveillance for detection and
monitoring of public health risks; ensure adequate response to public
health emergencies; and strengthen national laboratory capacity to
support effective public health responses, carryout diagnostic and
analytical tests, and build laboratory capacity nationwide to enable
the provision of quality laboratory services.
Summary of the Award:
Recipient: Ethiopian Public Health Institute (EPHI).
Purpose of the Award: The purpose of this award is to address gaps
identified in national HIV laboratory and surveillance systems and pave
the way for HIV epidemic control in Ethiopia.
Amount of Award: The approximate year 1 funding amount will be
$12,000,000 in Federal Fiscal Year (FFY) 2023 funds, subject to the
availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Period of Performance: September 30,2023 through September 29,
2028.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003).
Dated: March 16, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023-05822 Filed 3-21-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 22, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.